Patients who experience large fluctuations in their international normalized ratio (INR) measurement may benefit from supplementation with low-dose vitamin K. A small study of 8 highly motivated, adherent patients who were experiencing significant changes in their INR for no identifiable reason began taking 100 μg of vitamin K daily, similar to the usual daily vitamin K intake in the United States (60-90 μg).They began this therapy with the knowledge of their anticoagulation provider, and only when their INR was elevated or not significantly below their INR target.
The absolute number of INRs increased in range from 18% to 42% after supplementation. Only one patient failed to achieve better INR control. (This patient had lupus anticoagulant, which is known to interfere with INR measurements.) The authors concluded that these results warrant further study of the use of vitamin K for INR stabilization.
Patients who are selected for this therapy need to be monitored very carefully, as the INR may drop substantially during the initial 1 to 2 weeks of treatment. Patients should never begin vitamin K supplementation without the approval of their anticoagulation provider.
Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs